2026 ICD-10-PCS Procedure Code 3E0J3U1

3E0J3U1 PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is biliary and pancreatic tract.

MS-DRG Mapping for ICD-10-PCS Code 3E0J3U1

ICD-10-PCS procedure codes are grouped into Medicare Severity Diagnosis Related Groups (MS-DRGs) to support consistent hospital reimbursement and care planning. MS-DRGs classify inpatient stays based on clinical similarity and expected resource use, using information such as the primary procedure, secondary diagnoses, and patient condition.

Each hospital stay is assigned a single DRG, which determines a fixed payment rate from Medicare. This rate accounts for the complexity of the procedure and the overall cost of care.

The code 3E0J3U1 maps to the following MS-DRGs in version V43.0, effective from October 1, 2025, through September 30, 2026. These groupings are key to understanding how the procedure impacts billing and hospital resource allocation.

Convert to ICD-9-PCS

Below are the ICD-9=PCS code(s) that most closely match this ICD-10-PCS code, based on the General Equivalence Mappings (GEMs). This ICD-10-PCS to ICD-9-PCS crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.

Other ICD-10-PCS Codes Used for Introduction Biliary and Pancreatic Tract

Filter related codes list:

• 3E0J304 Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J305 Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J30M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J328 Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J329 Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J33Z Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J36Z Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J37Z Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3BZ Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3HZ Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3KZ Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3NZ Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3SF Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3TZ Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J3U0 Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach

• 3E0J4GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach

• 3E0J704 Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J705 Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J70M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J728 Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J729 Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J73Z Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J76Z Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J77Z Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7BZ Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7HZ Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7KZ Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7NZ Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7SF Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7TZ Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7U0 Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J7U1 Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

• 3E0J804 Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J805 Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J80M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J828 Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J829 Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J83Z Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J86Z Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J87Z Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8BZ Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8GC Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8HZ Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8KZ Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8NZ Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8SF Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8TZ Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8U0 Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

• 3E0J8U1 Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2026 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2025 through September 30, 2026.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.